iSelect Fund invests in early-stage, high-growth companies primarily in the Midwest, focusing on agriculture, food, health, and technology sectors. Their strategy emphasizes identifying ventures that solve real-world problems and generate both financial returns and positive impact.
40% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deals in the last 12 months vs 2 prior). Their most common stage is series-a (40% of deals). Average disclosed round size is $30.7M (across 10 rounds with reported amounts).
Portfolio
10
Fund Size
$147M
Top Stage
Series A
Last 12 Mo
1
Team
CE
Chas Eggert
Operating Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Mercy BioAnalytics, Inc. | Series B | $59M | Sep 2025 |
 Edacious | Seed | $8.1M | Feb 2025 |
 One Bio | Series A | $27M | Dec 2024 |
 EarthOptics | Series B | $27.6M | Jan 2023 |
 Bond Pet Foods | Series A | $17.5M | Sep 2022 |
| Bond Pet Foods | Series A | $17.5M | Jun 2022 |
 Molecular Assemblies Inc. | Series B | $25.8M | Mar 2022 |
 Sentera, LLC | Series C | $25M | Jun 2021 |
| GGeltor | Series B | $91.3M | Jul 2020 |
 Artemis | Series A | $8M | May 2019 |
Top Co-Investors
Cavallo Ventures2 shared
Leaps by Bayer2 shared
S2G Ventures2 shared
Lever VC1 shared
Route 66 Ventures1 shared
Astanor1 shared
Talis Capital1 shared
CPT Capital1 shared
Cultivian Sandbox1 shared
SOSV1 shared
Blue Horizon1 shared
RIT Capital Partners1 shared
Pegasus Tech Ventures1 shared
Alpha Edison1 shared
Morado Ventures1 shared
Better1 shared
Collaborative Fund1 shared
Sozo Ventures1 shared
Portfolia1 shared
Last updated: 5 March 2026